Could a tiny zap behind the ear tame migraine dizziness?
NCT ID NCT07368140
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests a new, non-drug treatment for vestibular migraine, a condition causing repeated dizziness and headaches. Fifty adults will receive either real or sham electrical stimulation behind the ears over six sessions. The main goal is to see if the treatment is safe and tolerable, and to gather early data on symptom improvement.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Electrical vestibular stimulation (gentle electrical signals behind the ears)
- What this could lead to
- If it works, this could point toward a drug-free treatment for vestibular migraine, reducing dizziness and headaches.
- What could go wrong
- This is a very early pilot study with only 50 people. It is designed mainly to test safety and feasibility, not to prove effectiveness. The sham group may show similar results.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VESTIBULAR MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Human Performance Laboratory, University of Calgary
Calgary, Alberta, T2N 1N4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Wearable eye-tracker aims to catch dizziness in the act
- Can a new migraine drug stop the dizzy spells?
- Ringing relief? migraine drugs tested for tinnitus in new study
- New wearable device aims to diagnose dizziness causes automatically
- New tool could help teens with dizzying migraines get better care
- Scientists hunt for genetic clues to Menière's disease